Congress pushes 10 drugmakers for heparin info

Unsatisfied with the information it has drawn from the FDA, a congressional committee is broadening its probe into the years-old heparin contamination scandal. The House Energy and Commerce Committee has written 10 drugmakers--including the Novartis generics unit Sandoz, APP Pharmaceuticals and Sanofi--demanding information about the heparin supply chain in China. Release | Letter